NIH

Kevin Murphy, Andrew W. Mellon Chair in the Humanities and professor of history of art and architecture, and Mary Anne Hunting, BA’80, have uncovered the histories of female architects in the American Modernism period of the U.S. in new research. Read More

A recent study by Paula Luis and Claus Schneider, researchers in the Vanderbilt University School of Medicine Basic Sciences Department of Pharmacology and the Vanderbilt Institute of Chemical Biology, has uncovered substantial inconsistencies in the alkaloid content of Corydalis yanhusuo dietary supplements. Read More

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. Read More

Submissions are open for pre-proposals for the 2025 National Institutes of Health S10 Shared and High-End Instrumentation Grant programs, which fund state-of-the-art shared research equipment. Internal pre-proposals are due by April 1, 2025, to allow institutional review before the June 2 NIH deadline, with guidance available from OVPRI and VBS. Read More

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read More

In 2024 the National Institutes of Health awarded Sando a New Innovator Award, part of their High-Risk, High-Reward Research program. This award, which provides $1,500,000 over five years, supports early-career scientists proposing innovative and impactful research that might not get funded in the traditional peer-review process due to its inherent risk. Read More

Krish Roy, Bruce and Bridgitt Evans Dean of the School of Engineering, recently engaged in a leadership roundtable in Washington, D.C. with NIH Director Dr. Monica M. Bertagnolli. Hosted by United for Medical Research (UMR), the forum addressed critical issues in biomedical research funding and efforts to secure sustained federal investments in this vital area. Read More

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years. Read More

Vanderbilt University has been awarded a prize from the National Institutes of Health for its creation of the LGBTQ+ Policy Lab, which advances a culture of inclusion for sexual and gender minority individuals through interdisciplinary research and collaboration. Read More

An $8.9 million grant from the NIH will establish the Vanderbilt AUD Research and Education Center, enhancing Vanderbilt University’s national leadership in neuroscience and addiction research. This initiative aims to foster interdisciplinary collaboration, advance understanding and treatment of alcohol use disorder, and engage the public through education and outreach efforts. Read More

Vanderbilt investigators who intend to apply for the 2024 NIH S10 either Shared or High-end Instrumentation Grant programs have until April 1 to submit an internal proposal for review. Read More

A multidisciplinary group of investigators from Vanderbilt University Medical Center, Vanderbilt University, and the University of Pennsylvania received a $3.2 million grant to develop novel brain network-based measures to guide surgical decisions and improve outcomes in the field of epilepsy surgery. Read More

Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity. Read More

A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. Read More

Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. Read More

The research team includes, left to right, Bruno Scaglioni, PhD; Keith Obstein MD, MPH; James Martin, PhD; Claire Landewee; Simone Calò, PhD; and Pietro Valdastri, PhD. (photo by Susan Urmy) by Jill Clendening A Vanderbilt Institute for Surgery and Engineering (VISE) research team is conducting the first phase 1 clinical trial of a magnetic, flexible... Read More

New faculty Makayla Cordoza will work with VUMC patients to assess their quality of sleep before and during hospitalization, to better understand how to prevent ICU delirium. Read More

Vanderbilt University faculty learned more about how ARPA-H funding can pave the way for transformative biomedical research. An information session, led by OVPRI and RDS, emphasized collaboration, innovation and the university’s commitment to pioneering health solutions. Read More

Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without serious neurological side effects. Merryman conducted... Read More

Vanderbilt researchers found reduced net flow of cerebrospinal fluid in Huntington’s disease, which could contribute to mutant protein retention and altered responsiveness to medications delivered via the spinal cord. Read More